<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai H</submitter><funding>National Natural Science Foundation of China</funding><pagination>1046-1057</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9790736</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>76(4)</volume><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Wilson's disease (WD) is a rare hereditary disorder due to ATP7B gene mutation, causing pathologic copper storage mainly in the liver and neurological systems. Hepatocyte transplantation showed therapeutic potential; however, this strategy is often hindered by a shortage of quality donor cells and by allogeneic immune rejection. In this study, we aimed to evaluate the function and efficacy of autologous reprogrammed, ATP7B gene-restored hepatocytes using a mouse model of WD.&lt;h4>Approach and results&lt;/h4>Sufficient liver progenitor cells (LPCs) were harvested by reprogramming hepatocytes from ATP7B&lt;sup>-/-&lt;/sup> mice with small molecules, which exhibited strong proliferation and hepatic differentiation capacity in vitro. After lentivirus-mediated mini ATP7B gene t</pubmed_abstract><journal>Hepatology (Baltimore, Md.)</journal><pubmed_title>ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.</pubmed_title><pmcid>PMC9790736</pmcid><funding_grant_id>81671103</funding_grant_id><pubmed_authors>Wang XP</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors><pubmed_authors>Cai H</pubmed_authors></additional><is_claimable>false</is_claimable><name>ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.</name><description>&lt;h4>Background and aims&lt;/h4>Wilson's disease (WD) is a rare hereditary disorder due to ATP7B gene mutation, causing pathologic copper storage mainly in the liver and neurological systems. Hepatocyte transplantation showed therapeutic potential; however, this strategy is often hindered by a shortage of quality donor cells and by allogeneic immune rejection. In this study, we aimed to evaluate the function and efficacy of autologous reprogrammed, ATP7B gene-restored hepatocytes using a mouse model of WD.&lt;h4>Approach and results&lt;/h4>Sufficient liver progenitor cells (LPCs) were harvested by reprogramming hepatocytes from ATP7B&lt;sup>-/-&lt;/sup> mice with small molecules, which exhibited strong proliferation and hepatic differentiation capacity in vitro. After lentivirus-mediated mini ATP7B gene t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-07-14T16:00:33.148Z</modification><creation>2025-04-05T08:47:27.354Z</creation></dates><accession>S-EPMC9790736</accession><cross_references><pubmed>35340061</pubmed><doi>10.1002/hep.32484</doi></cross_references></HashMap>